CA-AACE Hot Topics in Diabetes & Endocrinology for Primary Care, June 10, 2017, Monterey, CA
The California Chapter of AACE program committee has worked very hard to provide a relevant activity for the practicing clinical physician and other healthcare providers seeking education with an emphasis in endocrine disease.
This program has been planned to provide pertinent scientific and clinical information to help you achieve the best solutions in the diagnosis and therapeutic management of patients presenting with endocrine disease. Attendees will obtain updates in not only common and uncommon endocrine disorders, but also newer treatment modalities.
Endocrinologists, internists and other interested healthcare professionals in the state of California.
- How to implement the 2017 AACE Diabetes Algorithm into your practice (and make your life easier and patients happier!)
- Utilize opportunities to meet and exceed quality indicators for T2DM Treatment: Evaluating options with focus on incorporating: Incretin Rx (DPP4's and GLP-1) Therapy & SGLT2 Inhibitors-Potential and Pitfalls
- Discuss current DM medications that improve CV risk independent of glucose lowering
- Recognize when advanced Beta Cell failure is present and basal insulin is necessary
- Know when the newer basal insulin formulations are indicated and how to use these with other agents such as GLP-1 agonists
- Incorporate the newest methods to collect and interpret blood glucose data in your practice
- Identify key components in evaluating the ambulatory glucose profile in order to minimize glucose variability and hypoglycemia of patients with diabetes
- Understand why we have to move beyond LDL-C alone to lower risk further
- Introduce the New AACE Lipid Guidelines
- Incorporate new agents to lower LDL cholesterol into a treatment paradigm
- Be able to recommend optimal dietary regimens for patients with diabetes and cardiovascular risk factors.
- How to communicate to your patients about obesity and its associated health consequences and co-morbidities while acknowledging their main motivations
- Utilize the newest pharmacologic agents approved for use in obese patients
- Navigating billing procedures and insurance coverage (or lack thereof) for weight management in appropriate patients
- Enable Primary Care to be at the forefront of Fracture Risk Assessment and Osteoporosis Diagnosis
- Be able to undertake a Workup for Evaluating Secondary Causes of Osteoporosis and know when to refer out.
- Utilize Appropriate Treatment Modalities in Management of Patients with Osteoporosis
- Describe Non-Pharmacological Strategies for Fracture Prevention in Patients with Osteoporosis
David A. Chappell, MD
Chris Guerin, MD, FACE, FNLA
Assistant Clinical Professor of Medicine
University of California
Herbert I. Rettinger, MD, FACE
Past President, CA-AACE
Clinical Professor of Medicine/Endocrinology
University of California, Irvine, Volunteer Faculty
President, Endocrinology Medical Group of Orange County, Inc.
William D. Zigrang, MD, CCD, FACE
Board of Directors, AACE
Past President, California Chapter of AACE
Mills-Peninsula Health Systems,
The American Association of Clinical Endocrinologists (AACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Association of Clinical Endocrinologists (AACE) designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 4.50 AMA
- 4.50 Attendance